MedTrace Logo

The Value of Follow-Up After Childhood Acute Lymphoblastic Leukaemia in Denmark - Family Perspectives

NCT03985215 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-09-07

No results posted yet for this study

Summary

The aim of the study is to evaluate the family perspective on follow-up programs after treatment for childhood acute lymphoblastic leukaemia. It is relevant when new follow-up programs are to be designed.

Conditions

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Surveys and Questionnaires

Interventions

OTHER

Questionnaires

Pediatric Quality of Life Inventory questionnaire. Self-designed questionnaire.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Karen S Jensen, MD · Aarhus Universitet

Eligibility

Min Age
1 Year
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2021-07-31
Completion
2021-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03985215 on ClinicalTrials.gov